Campbell & Co. Investment Adviser »

Tg Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $603k 40k 15.21
2023-09-30 $361k 43k 8.36

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Tg Therapeutics

Vanguard Group
BlackRock
State Street Corporation
Soleus Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Wellington Management Company
Deep Track Capital
Susquehanna International
Citadel Advisors
Opaleye Management
Goldman Sachs Group
Bank of America Corporation
Marshall Wace
Sofinnova Ventures

View all funds holding Tg Therapeutics